Read More

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic

Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic compound aimed at treating postpartum depression (PPD.) 

MSSTF

Read More

Hawaiian Electric Industries Announces Appointments Of Paul Ito As CFO Through ~ December 31, 2024, Following Planned Retirement Of Tayne Sekimura; Utility Industry Veteran Scott DeGhetto To Join HEI As CFO Until Ito Resumes Position

HEI Chief Financial Officer Paul Ito to Become CFO of Hawaiian Electric Company Through Approximately December 31, 2024, Following Planned Retirement of Tayne SekimuraUtility Industry Veteran Scott DeGhetto to Join HEI

ALEX